Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2024.12.128 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Mahmoud B Malas und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA. Electronic address: mmalas@health.ucsd.edu. Hauptthemen laut MEDLINE: Chronic Limb-Threatening Ischemia, Endovascular Procedures, Kidney, Lower Extremity. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Chronic limb-threatening ischemia (CLTI) in patients with chronic kidney disease (CKD) has a high risk of poor outcomes. We aimed to compare the outcomes of lower extremity revascularization in patients with CLTI stratified by CKD severity in patients enrolled in the prospective, randomized Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial. METHODS: The BEST-CLI trial dataset was queried to categorize patients into three groups according to CKD stage. Group A includes non-CKD and CKD stages
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA. Electronic address: mmalas@health.ucsd.edu.
- Division of Vascular & Endovascular Surgery, Department of Surgery, UC San Diego (UCSD), La Jolla, CA.
- Division of Vascular & Endovascular Surgery, Department of Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
- Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Massachusetts, Boston, MA.
- Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA.
- Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Malas, M. B., Hamouda, M., Farber, A., Menard, M. T., Conte, M. S., Rosenfield, K., Strong, M. B., Doros, G., Powell, R. J., Mena-Hurtado, C., Gasper, W., Schermerhorn, M. L., Allievi, S., Smolderen, K. G., Dake, M. D., Rymer, J. A., & Tuttle, K. R. (2025). Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.12.128
Vancouver
Malas MB, Hamouda M, Farber A, Menard MT, Conte MS, Rosenfield K, et al. Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2024.12.128
BibTeX
@article{Malas2025,
author = {Malas, Mahmoud B and Hamouda, Mohammed and Farber, Alik and Menard, Matthew T and Conte, Michael S and Rosenfield, Kenneth and Strong, Michael B and Doros, Gheorghe and Powell, Richard J and Mena-Hurtado, Carlos and Gasper, Warren and Schermerhorn, Marc L and Allievi, Sara and Smolderen, Kim G and Dake, Michael D and Rymer, Jennifer A and Tuttle, Katherine R},
title = {Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2024.12.128}
}
EUVIMED